Ausgabe 4/2021
Inhalt (40 Artikel)
Abdelhamid H Elgazzar, Saud Alenezi (Eds). A concise guide to nuclear medicine. Second Edition
Luigi Mansi
The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection
Abass Alavi, Thomas J. Werner, Ali Gholamrezanezhad
[68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging
Rutger Mahieu, Gerard C. Krijger, F. F. Tessa Ververs, Remmert de Roos, Remco de Bree, Bart de Keizer
Brain insulin sensitivity is linked to body fat distribution—the positron emission tomography perspective
Eleni Rebelos, Lauri Nummenmaa, Prince Dadson, Aino Latva-Rasku, Pirjo Nuutila
In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers?
Varvara Valotassiou, George Angelidis, Dimitrios Psimadas, Ioannis Tsougos, Panagiotis Georgoulias
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy
Patrycja Guzik, Martina Benešová, Magdalena Ratz, Josep M. Monné Rodríguez, Luisa M. Deberle, Roger Schibli, Cristina Müller
Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model
Patrycja Guzik, Klaudia Siwowska, Hsin-Yu Fang, Susan Cohrs, Peter Bernhardt, Roger Schibli, Cristina Müller
A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET
Pavel Nikulin, Frank Hofheinz, Jens Maus, Yimin Li, Rebecca Bütof, Catharina Lange, Christian Furth, Sebastian Zschaeck, Michael C. Kreissl, Jörg Kotzerke, Jörg van den Hoff
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials
Bastien Jamet, Ludivine Morvan, Cristina Nanni, Anne-Victoire Michaud, Clément Bailly, Stéphane Chauvie, Philippe Moreau, Cyrille Touzeau, Elena Zamagni, Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Diana Mateus, Thomas Carlier
Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM
Riemer H. J. A. Slart, Andor W. J. M. Glaudemans, Olivier Gheysens, Mark Lubberink, Tanja Kero, Marc R. Dweck, Gilbert Habib, Oliver Gaemperli, Antti Saraste, Alessia Gimelli, Panagiotis Georgoulias, Hein J. Verberne, Jan Bucerius, Christoph Rischpler, Fabien Hyafil, Paola A. Erba
EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging
Roberto Sciagrà, Mark Lubberink, Fabien Hyafil, Antti Saraste, Riemer H. J. A. Slart, Denis Agostini, Carmela Nappi, Panagiotis Georgoulias, Jan Bucerius, Christoph Rischpler, Hein J. Verberne
Multiparametric PET and MRI of myocardial damage after myocardial infarction: correlation of integrin αvβ3 expression and myocardial blood flow
Marcus R. Makowski, Christoph Rischpler, Ullrich Ebersberger, Alexandra Keithahn, Markus Kasel, Ellen Hoffmann, Tienush Rassaf, Horst Kessler, Hans-Jürgen Wester, Stephan G. Nekolla, Markus Schwaiger, Ambros J. Beer
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
Armin Frille, Michael Rullmann, Georg-Alexander Becker, Marianne Patt, Julia Luthardt, Solveig Tiepolt, Hubert Wirtz, Osama Sabri, Swen Hesse, Hans-Juergen Seyfarth
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
Mona-Lisa Malarte, Agneta Nordberg, Laetitia Lemoine
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
Igor D. Grachev, Philipp M. Meyer, Georg A. Becker, Marcus Bronzel, Doug Marsteller, Gina Pastino, Ole Voges, Laura Rabinovich, Helena Knebel, Franziska Zientek, Michael Rullmann, Bernhard Sattler, Marianne Patt, Thilo Gerhards, Maria Strauss, Andreas Kluge, Peter Brust, Juha-Matti Savola, Mark F. Gordon, Michal Geva, Swen Hesse, Henryk Barthel, Michael R. Hayden, Osama Sabri
Visual interpretation of [18F]Florbetaben PET supported by deep learning–based estimation of amyloid burden
Ji-Young Kim, Dongkyu Oh, Kiyoung Sung, Hongyoon Choi, Jin Chul Paeng, Gi Jeong Cheon, Keon Wook Kang, Dong Young Lee, Dong Soo Lee
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study
Antonio Canosa, Andrea Calvo, Cristina Moglia, Umberto Manera, Rosario Vasta, Francesca Di Pede, Sara Cabras, Davide Nardo, Vincenzo Arena, Maurizio Grassano, Fabrizio D’Ovidio, Koen Van Laere, Philip Van Damme, Marco Pagani, Adriano Chiò
Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version)
Xiaoli Lan, Yu Long, Fuqiang Shao , Yangminghui Song
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
G. Manson, P. Brice, C. Herbaux, M. G. Silva, K. Bouabdallah, B. Deau, J. Bouteloup, J. M. Schiano, E. Nicolas-Virelizier, M. Maerevoet, H. Ghesquieres, A. Stamatoullas, C. Antier, C. Carlo-Stella, M. de Charette, F. Poizeau, L. Dercle, Roch Houot
18F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study
Julian Kirchner, Vaios Hatzoglou, Justin B. Buthorn, Dana Bossert, Allison M. Sigler, Anne S. Reiner, Gary A. Ulaner, Eli L. Diamond
IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab—pharmacokinetic modeling to optimize therapeutic index
Rahul S. Yerrabelli, Ping He, Edward K. Fung, Kim Kramer, Pat B. Zanzonico, John L. Humm, Hongfen Guo, Neeta Pandit-Taskar, Steven M. Larson, Nai-Kong V. Cheung
Improved cancer detection in Waldeyer’s tonsillar ring by 68Ga-FAPI PET/CT imaging
S. Serfling, Y. Zhi, A. Schirbel, T. Lindner, T. Meyer, E. Gerhard-Hartmann, C. Lapa, R. Hagen, S. Hackenberg, A. K. Buck, A. Scherzad
EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0
Judit A. Adam, Annika Loft, Cyrus Chargari, Roberto C. Delgado Bolton, Elisabeth Kidd, Heiko Schöder, Patrick Veit-Haibach, Wouter V. Vogel
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Robert Seifert, Katharina Kessel, Katrin Schlack, Manuel Weber, Ken Herrmann, Maximilian Spanke, Wolfgang P. Fendler, Boris Hadaschik, Jens Kleesiek, Michael Schäfers, Matthias Weckesser, Martin Boegemann, Kambiz Rahbar
Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer
Cédric Draulans, Robin De Roover, Uulke A. van der Heide, Linda Kerkmeijer, Robert J. Smeenk, Floris Pos, Wouter V. Vogel, James Nagarajah, Marcel Janssen, Sofie Isebaert, Frederik Maes, Cindy Mai, Raymond Oyen, Steven Joniau, Martina Kunze-Busch, Karolien Goffin, Karin Haustermans
Improved oncological outcome after radical prostatectomy in patients staged with 68Ga-PSMA-11 PET: a single-center retrospective cohort comparison
Daniela A. Ferraro, Fabienne Lehner, Anton S. Becker, Benedikt Kranzbühler, Ken Kudura, Iliana Mebert, Michael Messerli, Thomas Hermanns, Daniel Eberli, Irene A. Burger
Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use
Marina Hodolic, Wen-Yu Wu, Zhenyu Zhao, Fei Yu, Irene Virgolini, Feng Wang
Improving staging of rectal cancer in the pelvis: the role of PET/MRI
Onofrio A. Catalano, Susanna I. Lee, Chiara Parente, Christy Cauley, Felipe S. Furtado, Robin Striar, Andrea Soricelli, Marco Salvatore, Yan Li, Lale Umutlu, Lina Garcia Cañamaque, David Groshar, Umar Mahmood, Lawrence S. Blaszkowsky, David P. Ryan, Jeffrey W. Clark, Jennifer Wo, Theodore S. Hong, Hiroko Kunitake, Liliana Bordeianou, David Berger, Rocco Ricciardi, Bruce Rosen
[68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy for sentinel lymph node detection in early-stage oral cavity carcinoma
Rutger Mahieu, Gerard C. Krijger, F.F. Tessa Ververs, Remmert de Roos, Remco de Bree, Bart de Keizer
The superiority of [68Ga]-FAPI-04 over [18F]-FDG PET/CT in imaging metastatic esophageal squamous cell carcinoma
Qiufang Liu, Si Shi, Xiaoping Xu, Xianjun Yu, Shaoli Song
The use of 18F-FDG PET/CT to guide management of adrenal histoplasmosis over time
S. Parisien-La Salle, P. Morency-Potvin, M. Lord, F. Mercier, B. P. Dubé, C. Cohade, I. Bourdeau
18F-FDG simultaneous PET/MR monitoring treatment response of a Turcot syndrome case
Haiyan Wang, Qiaoyi Xue, Zhiwen You, Xing Chen, Jianmin Yuan, Jun Zhao
[68Ga]Ga-DOTA-FAPI-04 PET/CT imaging in a case of prostate cancer with shoulder arthritis
Tingting Xu, Yan Zhao, Haoyuan Ding, Liang Cai, Zhijun Zhou, Zhenyu Song, Yue Chen
An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [18F]FDG PET/CT
Kip E. Guja, Ryanne Brown, Brad Girod, Hong Song, Caitlyn Harrison, Benjamin L. Franc, Farshad Moradi, Guido Davidzon, Andrei Iagaru, Carina Mari Aparici
A malignant birthmark detected by 18F-FDG PET/CT in a patient with esophageal cancer
Lijuan Wang, Yin Zhang
Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT
A. Gosewisch, M. Schleske, F. J. Gildehaus, I. Berg, L. Kaiser, J. Brosch, P. Bartenstein, A. Todica, H. Ilhan, G. Böning
Response to 225Ac-PSMA-I&T after failure of long-term 177Lu-PSMA RLT in mCRPC
Harun Ilhan, Astrid Gosewisch, Guido Böning, Friederike Völter, Mathias Zacherl, Marcus Unterrainer, Peter Bartenstein, Andrei Todica, Franz Josef Gildehaus
Diffuse multiple organs uptake of 99mTc-MDP on SPECT/CT
Maoqing Jiang, Ping Chen, Yu Chu
A rare case of cranial and spinal leptomeningeal dissemination of recurrent ethmoid carcinoma detected by [18F]-FDG PET/CT
Kota Yokoyama, Osamu Manabe, Jyunichi Tsuchiya, Jun Oyama, Hiroaki Kawabe, Yumiko Tateishi, Takahiro Asakage, Kouhei Yamamoto, Ukihide Tateishi
Detection of pseudoprogression with [18F]-FDG-PET in a patient with pulmonary large cell neuroendocrine carcinoma who received anti-PD-1 treatment
Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, Hiroshi Kagamu